Live Breaking News & Updates on Consumer health segment

Stay informed with the latest breaking news from Consumer health segment on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Consumer health segment and stay connected to the pulse of your community

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During ...

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During ...

United-states , Denver , Colorado , Josh-disbrow , Aytu-rxconnect , Consumer-health-segment , News-network , Company-consumer-health-segment , Company-rx-segment , Company-or-aytu , Aytu-biopharma-inc , Aytu-biopharma

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted EBITDA of $5.5 millionQ2 2024 ADHD Portfolio net revenue up 49% compared to Q2 2023$19.5 million cash balance at Decem...

United-states , Denver , Colorado , Roger-weiss , Josh-disbrow , Mark-oki , Aytu-rxconnect , Consumer-health-segment , Company-consumer-health-segment , Consumer-health , Aytu-biopharma-inc , Securities-exchange

Catalent, Inc. Reports Second Quarter Fiscal 2024 Results

Q2'24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency, compared to Q2'23.

Q2'24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and...

United-states , New-jersey , Russia , Ukraine , Ukrainian , Russian , Alessandro-maselli , Catalent-biomodalities , Novo-holdings , Company-biomodalities , Company-consumer-health , Consumer-health

Catalent: Debt Remains An Overhang (NYSE:CTLT)

Catalent: Debt Remains An Overhang (NYSE:CTLT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

New-jersey , United-states , Catalent-pharma , Iceberg-slim , Robertw-baird , Catalent-inc , Guidance-reaffirmed-november-company-presentation , Consumer-health , Company-presentation , Cash-flow-november-company-presentation , Consumer-health-segment , Wells-fargo

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Grand-prairie , Texas , United-states , Denver , Colorado , Josh-disbrow , Roger-weiss , Aytu-rxconnect , Mark-oki , Aytu-biopharma , Us-food-drug-administration , Consumer-health-segment

Catalent (CTLT) Reports Prelim Q3 Revenue of $982M, EPS of ($0.10), Reaffirms FY24 Guidance

Catalent (CTLT) Reports Prelim Q3 Revenue of $982M, EPS of ($0.10), Reaffirms FY24 Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ukraine , Russia , New-jersey , United-states , Ukrainian , Russian , Alessandro-maselli , Paul-surdez , Catalent-biomodalities , Securities-exchange , Consumer-health-segment , Exchange-commission

Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Ihren , Rheinland-pfalz , Germany , United-states , Texas , Denver , Colorado , Grand-prairie , Mark-oki , Roger-weiss , Aytu-biopharma , Josh-disbrow

Aytu BioScience (AYTU) Reports Q1 Revenue of $22.1M, Net Loss of $8.1M

Aytu BioScience (AYTU) Reports Q1 Revenue of $22.1M, Net Loss of $8.1M
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Grand-prairie , Texas , United-states , Aytu-rxconnect , Mark-oki , Aytu-biopharma , Roger-weiss , Josh-disbrow , Nasdaq , Consumer-health-segment , Consumer-health , Exchange-commission

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
baltimorestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimorestar.com Daily Mail and Mail on Sunday newspapers.

Grand-prairie , Texas , United-states , Denver , Colorado , Aytu-rxconnect , Mark-oki , Aytu-biopharma , Roger-weiss , Josh-disbrow , Consumer-health-segment , Company-or-aytu

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United-states , Denver , Colorado , Aytu-rxconnect , Aytu-biopharma , Josh-disbrow , Company-consumer-health , Consumer-health , News-network , Aytu-biopharma-inc , Company-or-aytu , Consumer-health-segment